NZME's Strategic Review and Activist Involvement Signal Potential Value Unlock Through OneRoof Spin-Off and Board Overhaul
NZME Limited's strategic review of OneRoof aims for potential separation, with activist Jim Grenon acquiring a 13.5% stake.
142 Views
Lifeway Foods Faces Potential Sale to Danone Amidst Board Overhaul and Family Feud Resolution by June 2025
Danone offered to buy Lifeway at $25/share in September 2024, raised to $27/share in November 2024.
419 Views
Ping An's Strategic Buyout of OneConnect: Navigating Shareholder Approval and Financial Implications Amidst Declining Performance
OneConnect received a non-binding acquisition proposal from Ping An Group at $7.98/ADS, requiring 75% shareholder approval.
1.4k Views
Sun Pharma's Acquisition of Checkpoint Therapeutics: Analyzing the CVR Payout Potential and Strategic Implications
Checkpoint Therapeutics is being acquired by Sun Pharma for $4.1/share plus a non-transferable CVR worth up to $0.70/share.
499 Views
SSI Weekly: WEX Tender Offer, SGRP Gains, OCI Asset Sale, CURN Strategy, and Quick Pitch Updates
WEX Inc. launched a $750m tender offer with an odd-lot provision, targeting to repurchase ~12% of shares. OCI N.V.'s Natgasoline JV dispute...
422 Views